Roche Holding AG - 53 Year Dividend History | RHHBY

Historical dividend payout and yield for Roche Holding AG (RHHBY) since 1972. The current TTM dividend payout for Roche Holding AG (RHHBY) as of June 04, 2025 is $0.87. The current dividend yield for Roche Holding AG as of June 04, 2025 is 2.14%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $260.220B $68.726B
Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its operations through two segments ' Pharmaceuticals and Diagnostics.Pharmaceuticals: Key focus areas in this segment include Oncology, Virology, Inflammation, Metabolism and Neuroscience. Diagnostics: The Diagnostics Division operates in four segments ' Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics. In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $725.814B 55.66
Johnson & Johnson (JNJ) United States $368.659B 15.25
AbbVie (ABBV) United States $330.918B 18.24
Novartis AG (NVS) Switzerland $247.027B 14.11
Merck (MRK) United States $196.538B 10.05
Pfizer (PFE) United States $132.981B 7.29
Sanofi (SNY) France $121.397B 11.96
Bayer (BAYRY) Germany $28.333B 5.77
Innoviva (INVA) United States $1.311B 13.74
Novo Nordisk (NVO) Denmark $0.000B 21.31